The inspiring story of Emma Betts premieres on Australian Story
16 April 2018
Emma Betts was only 22 years old when she learned that she had stage 4 melanoma. Emma shared her story with many by documenting her experience with melanoma on her blog Dear Melanoma. She sadly passed away at the age of 25 in April, 2017.
Australian Story's 'Dear Emma' is a tribute to the life and times of a young woman determined to raise awareness about melanoma. A true tear-jerker, the segment will explore how Emma and her husband Serge dealt with her heartbreak and how her parents Tamra and Leon, are continuing Emma’s legacy of encouraging others to contribute to life-saving research.
Although Emma was not a patient of Melanoma Institute Australia, she cared very deeply about people with melanoma and people at risk of melanoma around the country. She did everything she could to get the word out and raised a lot of funds for research at MIA - which reveals the complexity of the drivers of melanoma in younger people. It's not only about sun damage.
We're committed to weaving Emma's loving legacy into the work we'll be undertaking to draw attention to melanoma in young Australians and the research, treatment and education strategies we need to stop losing them to this disease.
Emma Betts started the national conversation about melanoma that Australia has to have. To continue Emma’s legacy, we need to keep that conversation going.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.
More than 150 clinicians, researchers and MIA staff gathered online to share research highlights.
Independent researchers at The University of Sydney are seeking patient feedback.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Postponed to early 2022. Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.